FDA Clearance Tracker · K033484
HUMAN HEART VALVE, CRYOVALVE SG
Last checked: Nov 19, 2026Latest source record: Feb 7, 2008 (this decision)Source: openFDAMethods & limitations
Decided
Feb 7, 2008
Substantially Equivalent
Time to decision
1,556 days
Received Nov 4, 2003. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Unclassified
The decision
- FDA number
- K033484
- Device name
- HUMAN HEART VALVE, CRYOVALVE SG
- Applicant
- Cryolife, Inc.
- Applicant location
- Kennesaw, GA
- Received
- Nov 4, 2003
- Decided
- Feb 7, 2008
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device class
- Unclassified
- Specialty
- CardiologyInterventional Cardiology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- This is the earliest decision in FDA's data under product code OHA (Heart Valve, More Than Minimally Manipulated Allograft).
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K033484
- The applicant filed a summary instead of a public summary, or the summary is not at FDA's usual address. Check the FDA record.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Cryolife, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K183635 · Decided Feb 14, 2019 · 50 days after receipt
Device type: Intracardiac Patch Or Pledget, Biologically Derived (PSQ) · Cardiology
K172085 · Decided Dec 4, 2017 · 146 days after receipt
Device type: Intracardiac Patch Or Pledget, Biologically Derived (PSQ) · Cardiology
K162506 · Decided Mar 9, 2017 · 182 days after receipt
Device type: Patch, Pledget And Intracardiac, Petp, Ptfe, Polypropylene (DXZ) · Cardiology
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.